{"Title": ["Aerie Pharmaceuticals Inc (AERI) Q1 2020 Earnings Call Transcript", "So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be Premature", "Healthcare Pro James Flynn Picks up These 3 Stocks on the Cheap", "Aerie Pharmaceuticals Inc (AERI) Q4 2019 Earnings Call Transcript", "Here's Why Aerie Pharmaceuticals Jumped as Much as 14.4% Today", "Stock Alert: Aerie Pharma (AERI) Catches Eye", "5 \u201cStrong Buy\u201d Biotech Stocks With More Than 80% Upside", "Noteworthy Tuesday Option Activity: AERI, CVNA, NTAP", "Aerie Pharmaceuticals Inc (AERI) Q1 2020 Earnings Call Transcript", "Why Aerie Pharmaceuticals Crashed 22.4% Today", "Aerie Pharmaceuticals Inc (AERI) Q3 2019 Earnings Call Transcript", "Is Aerie Pharmaceuticals a Buy?", "Here's Why Aerie Pharmaceuticals Rose as Much as 21.8% Today", "Insiders Now Seeing Red With AERI At New 52-Week Low", "Health Care Sector Update for 09/20/2019: NSPR, HTGM, AERI, JNJ, PFE, ABT, MRK, AMGN", "Tuesday 9/10 Insider Buying Report: AERI, NKTR", "Can Aerie Pharmaceuticals Go From 1.5% of the Glaucoma Market to 40%?", "Interesting AERI Put And Call Options For February 2020", "Notable Thursday Option Activity: AERI, KNX, TSN", "Aerie (AERI) Improves 22% YTD: Is Momentum Likely to Sustain?", "Aerie (AERI) Down 2.9% Since Last Earnings Report: Can It Rebound?", "Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan", "First Week of November 15th Options Trading For Aerie Pharmaceuticals", "Aerie (AERI) Starts Phase II Study on Eye Candidate AR-1105", "Aerie Pharmaceuticals, Inc. (AERI) Q2 2019 Earnings Call Transcript", "Interesting AERI Put And Call Options For February 2020", "Notable Thursday Option Activity: AERI, KNX, TSN", "The 9 Best Biotech Stocks to Buy for a Blowout 2019", "Aerie Pharmaceuticals Enters Overbought Territory: Is A Drop Coming?", "Aerie's (AERI) Eye Care Candidate to Enter Clinical Studies", "Aerie's Rhopressa Succeeds in Study on Japanese Patients", "Aerie (AERI) Down 19.9% Since Last Earnings Report: Can It Rebound?", "Aerie (AERI) Receives FDA Nod for Rocklatan to Treat Glaucoma", "Aerie (AERI) Q4 Earnings Miss, Rhopressa Gains Traction", "Aerie Pharmaceuticals Inc (AERI) Q4 2018 Earnings Conference Call Transcript", "The 9 Best Biotech Stocks to Buy for a Blowout 2019", "Aerie Pharmaceuticals Enters Overbought Territory: Is A Drop Coming?", "Aerie's (AERI) Eye Care Candidate to Enter Clinical Studies", "Aerie's Rhopressa Succeeds in Study on Japanese Patients", "December 2019 Options Now Available For Aerie Pharmaceuticals (AERI)", "Aerie Pharmaceuticals (AERI): Moving Average Crossover Alert", "Has Aerie Pharmaceuticals (AERI) Outpaced Other Medical Stocks This Year?", "Jazz Pharma's (JAZZ) Stock Down Despite Q2 Earnings Beat", "Aerie Pharmaceuticals (AERI) Reports Q2 Loss, Tops Revenue Estimates", "BioMarin (BMRN) Q2 Earnings Miss Estimates, Revenues Beat", "Noteworthy Friday Option Activity: LNG, AERI, EPC", "Medical-Drugs Stock Outlook: No Respite from Near-Term Pain", "Aerie (AERI) to Report Q2 Earnings: What's in the Offing?", "Aerie (AERI) Earnings Miss in Q2, Rhopressa Performs Well", "Has Aerie Pharmaceuticals (AERI) Outpaced Other Medical Stocks This Year?", "Jazz Pharma's (JAZZ) Stock Down Despite Q2 Earnings Beat", "Aerie Pharmaceuticals (AERI) Reports Q2 Loss, Tops Revenue Estimates", "AERI Makes Bullish Cross Above Critical Moving Average", "Aerie Pharmaceuticals is Now Oversold (AERI)", "Aerie (AERI) Incurs Lower Loss in Q1, Launches Rhopressa", "What's in the Cards for Aerie (AERI) This Earnings Season?", "Aerie Pharmaceuticals May Revolutionize Glaucoma Treatment", "Analysts Expect 13% Gains Ahead For VBR", "Aerie Pharmaceuticals (AERI) Up 4.6% Since Earnings Report: Can It Continue?", "Aerie Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for AERI", "Aerie's (AERI) Q4 Loss Wider on Higher Operating Expenses", "Why Earnings Season Could Be Great for Aerie Pharmaceuticals (AERI)", "Will Admissions Drive Universal Health's (UHS) Q4 Earnings?", "Will Admissions Drive Universal Health's (UHS) Q4 Earnings?", "Commit To Purchase Aerie Pharmaceuticals At $40, Earn 13.3% Annualized Using Options", "Noteworthy Friday Option Activity: EVC, AERI, AA", "Noteworthy Wednesday Option Activity: AERI, CHRW, NXPI", "Aerie Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for AERI", "Health Care Sector Update for 01/24/2018: JNJ, PFE, ABT, MRK, AMGN, STML, AERI, BSX", "Why Valeant's 162% Climb Over Nine Months 'Makes No Sense'", "Noteworthy Wednesday Option Activity: TER, AERI, MTOR", "Aerie Pharmaceuticals Sees IBD RS Rating Improve To 74", "Can Rhopressa's Approval Drive Aerie (AERI) in Q4 Earnings?", "Noteworthy Friday Option Activity: EVC, AERI, AA", "Noteworthy Wednesday Option Activity: AERI, CHRW, NXPI", "Aerie Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for AERI", "Health Care Sector Update for 01/24/2018: JNJ, PFE, ABT, MRK, AMGN, STML, AERI, BSX", "Aerie (AERI) Gets Early FDA Approval for Lead Drug Rhopressa", "Why Is Aerie (AERI) Down 5.9% Since the Last Earnings Report?", "Jacobs (JEC) to Boost Organic Growth on Energy Contract", "Falling Earnings Estimates Signal Weakness Ahead for Aerie Pharmaceuticals (AERI)", "Aerie (AERI) Q3 Loss Wider Than Expected, Pipeline in Focus", "Is a Surprise Coming for Aerie (AERI) This Earnings Season?", "Is Aerie (AERI) Poised for a Beat This Earnings Season?", "Notable Monday Option Activity: AERI, CVLT, TWTR", "Aerie (AERI) Up on FDA Review Committee Result for Rhopressa", "Jacobs' South African JV Business Wins New Deal from Sasol", "Aerie Pharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS Rating", "Aerie Pharmaceuticals (AERI) Surges: Stock Moves 16.2% Higher", "Aerie Pharmaceuticals Scores Relative Strength Rating Upgrade", "Wednesday's ETF with Unusual Volume: IWV", "Notable Wednesday Option Activity: AERI, STZ, DNKN", "A Drug Sent This Biotech To A Fresh High \u2014 But There's A Caveat", "Health Care Sector Update for 10/11/2017: AERI,AKTX,ATEC", "This Biotech Yo-Yos After FDA Panel Recommends Glaucoma Drug", "Jacobs (JEC) Wins New Transportation Contracts from NTA", "Aerie Pharmaceuticals Earns Relative Strength Rating Upgrade; Hits Key Threshold", "Jacobs (JEC) Poised to Grow on Divestitures, Contract Wins", "Aerie Pharmaceuticals Sees IBD RS Rating Climb To 73", "First Week of AERI May 2018 Options Trading", "Jacobs (JEC) Awarded EPCM Contract by Aerie Pharmaceuticals", "Are Options Traders Betting on a Big Move in Aerie (AERI) Stock?", "Stocks Showing Rising Market Leadership: Aerie Pharmaceuticals Earns 82 RS Rating", "Aerie Initiates Phase III Study for Ophthalmic Drug Roclatan", "Ultragenyx Files BLA to FDA for Hypophosphatemia Candidate", "Ultragenyx (RARE) Posts Disappointing Phase III Ace-ER Data", "Noteworthy Thursday Option Activity: LSTR, CACC, AERI", "Health Care Sector Update for 08/09/2017: AERI", "Spectrum Pharmaceuticals (SPPI) Looks Good: Stock Jumps 22.2%", "Aerie (AERI) Reports Narrower-Than-Expected Loss in Q2", "Why Is Aerie (AERI) Up 10% Since the Last Earnings Report?", "What's in the Cards for Aerie (AERI) This Earnings Season?", "New Strong Buy Stocks for July 24th", "Commit To Purchase Aerie Pharmaceuticals At $40, Earn 13% Using Options", "Esperion Therapeutics (ESPR) Looks Good: Stock Gains 10.4%", "Immune Design (IMDZ) Shows Strength: Stock Moves 6.2% Higher", "Can The Uptrend Continue for Aerie Pharmaceuticals (AERI)?", "Radius Health (RDUS) Looks Good: Stock Adds 10.5% in Session", "New Strong Buy Stocks for August 2nd", "What's in the Cards for Aerie (AERI) This Earnings Season?", "Pre-Market Most Active for May 25, 2017 : BBY, QQQ, CWH, ANF, BP, AERI, SNY, NTEST, BCRX, XIV, SNDX, NFLX", "Why Sears Holdings, Aerie Pharmaceuticals, and Guess? Jumped Today", "Aerie's Ophthalmic Candidate Positive in Registration Trial", "Health Care Sector Update for 05/25/2017: AERI,BCRX,CORI", "GlycoMimetics (GLYC) Shows Strength: Stock Jumps 98.7%", "Why Is Aerie (AERI) Up 40.4% Since the Last Earnings Report?", "MEI Pharma (MEIP) Shows Strength: Stock Moves 7.6% Higher", "Why Aerie Pharmaceuticals Inc. Is Skyrocketing Today", "Pre-Market Most Active for May 25, 2017 : BBY, QQQ, CWH, ANF, BP, AERI, SNY, NTEST, BCRX, XIV, SNDX, NFLX", "Why Sears Holdings, Aerie Pharmaceuticals, and Guess? Jumped Today", "Aerie (AERI) Posts Wider-Than-Expected Q1 Loss, Expenses Up", "What Awaits Aerie Pharmaceuticals (AERI) in Q1 Earnings?", "Friday 4/21 Insider Buying Report: JPM, AERI", "ImmunoGen (IMGN) Shows Strength: Stock Up 14.2% Higher", "Cardiome Pharma (CRME) Looks Good: Stock Moves 6.1% Higher", "Aerie (AERI) Down 12.9% Since Earnings Report: Can It Rebound?", "Valeant's (VRX) Glaucoma Candidate Gets PDUFA Date from FDA", "Aerie Resubmits Rhopressa NDA, Roclatan Gains Traction", "Aerie (AERI) Q4 Loss Widens, Rhopressa NDA Resubmitted", "After-Hours Earnings Report for March 7, 2017 : HRB, URBN, ABM, AERI, NCS, ALG, EDIT, NMBL, BOJA, AFAM, AVAV, RGNX", "Implied Volatility Surging for Aerie Pharmaceuticals (AERI) Stock Options", "Noteworthy Wednesday Option Activity: GBT, JACK, AERI", "Ocular (OCUL) Reports Positive Phase III Data on Eye Drug", "Inotek (ITEK) Down on Poor Phase III Glaucoma Drug Data", "Commit To Buy Aerie Pharmaceuticals At $22.50, Earn 19.1% Using Options", "Aerie (AERI) Rhopressa Regulatory Application Delayed Again", "Aerie (AERI) Q3 Loss Wider than Expected, Pipeline in Focus", "Cigna (CI) Poised to Beat on Earnings in Q3: Here's Why", "Aerie Pharmaceuticals (AERI) Q4 Earnings: What to Expect?", "Noteworthy Wednesday Option Activity: GBT, JACK, AERI", "Ocular (OCUL) Reports Positive Phase III Data on Eye Drug", "Conatus (CNAT) Q3 Earnings: What's in Store for the Stock?", "Celldex (CLDX): Will the Stock Surprise in Q3 Earnings?", "Endocyte (ECYT): Can the Stock Surprise in Q3 Earnings?", "Ligand (LGND) Q3 Earnings: Is the Stock Likely to Disappoint?", "Pfizer (PFE) to Post Q3 Earnings: How Will the Stock React?", "Horizon (HZNP) Q3 Earnings Preview: Stock to Disappoint?", "Aerie Pharmaceuticals (AERI) Q3 Earnings: Will It Beat?", "Can Prothena (PRTA) Pull a Surprise This Earnings Season?", "6 Best Performing Drug Stocks of September", "Aerie Pharmaceuticals Could Still Be a Bargain After Its Run-Up", "3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions", "What's Behind Aerie Pharmaceuticals' 12.9% Rally Today", "Company News for September 16, 2016", "Zoetis (ZTS) Q3 Earnings: Stock Likely to Beat Estimates", "Aerie Pharmaceuticals (AERI) Q3 Earnings: Will It Beat?", "Can Prothena (PRTA) Pull a Surprise This Earnings Season?", "Pre-Market Most Active for Sep 15, 2016 : AEG, AAPL, AZN, AERI, XIV, QQQ, ACRX, TTM, BAC, TVIX, NOK, CS", "3 Stocks to Watch Thursday: Viacom, Inc. (VIAB), Aerie Pharmaceuticals Inc (AERI) and Bluebird Bio Inc (BLUE)", "What Happened in the Stock Market Today", "Close Update: Stocks Rally as Economic Data Cools Rate Hike Jitters", "Health Care Sector Update for 09/15/2016: XNCR,AERI,GBSN", "Why Aerie Pharmaceuticals Shares Are Rallying Another 11.9% Today", "Stock Futures Trim Gains as Econ Data Fails to Extinguish Rate Hike Jitters", "Aerie (AERI) Stock Up on Positive Phase III Data on Roclatan", "Pre-Market Most Active for Sep 15, 2016 : AEG, AAPL, AZN, AERI, XIV, QQQ, ACRX, TTM, BAC, TVIX, NOK, CS", "3 Stocks to Watch Thursday: Viacom, Inc. (VIAB), Aerie Pharmaceuticals Inc (AERI) and Bluebird Bio Inc (BLUE)", "What Happened in the Stock Market Today", "Aerie (AERI) Q2 Loss Wider than Expected, Pipeline in Focus", "Aerie owner buys 250,000 shares", "Midday Update: Stocks Buoyed by Anemic Retail Sales, Support For S&P 500 at 2,120", "What Awaits Aerie Pharmaceuticals (AERI) in Q2 Earnings?", "Notable Wednesday Option Activity: BOX, AERI, AIG", "Aerie (AERI) Q1 Loss Wider than Expected, Pipeline in Focus", "Drug Stocks Q1 Earnings Preview: AEGR, AERI, MACK, PRTA", "Aerie (AERI): Can the Stock Pull a Surprise in Q1 Earnings?", "Will Aerie Pharmaceuticals (AERI) Continue to Surge Higher?", "Thursday's ETF Movers: XPH, XRT", "Drug Stocks to Watch for Earnings on Aug 3: ZTS, EXEL & More", "Health Care Sector Update for 03/28/2016: AERI,ALDR,APRI", "Health Care Sector Update for 03/03/2016: AERI,CRMD,SSH", "Aerie (AERI) Q4 Loss Wider than Expected, Pipeline in Focus", "After-Hours Earnings Report for March 1, 2016 : ROST, GWRE, VEEV, ASNA, NKTR, DAR, SQM, BOBE, TIVO, CHUY, EPIQ, AERI", "Health Care Sector Update for 02/18/2016: AERI, ATHX, CSLT", "Why Safety Data Is Sending Aerie Pharmaceuticals Soaring Today", "Aerie (AERI) Reports Positive Interim Results on Rhopressa", "Aerie Starts Dosing in Registration Trial Mercury 2 on Roclatan", "Synthetic Biologics Posts Encouraging Data on SYN-010", "The Zacks Analyst Blog Highlights: Aerie Pharmaceuticals, United Therapeutics, Pacira Pharmaceuticals, Ohr Pharmaceutical and Infinity Pharmaceuticals", "Nivalis Therapeutics (NVLS) Jumps: Stock Moves Up 15.5%", "6 Drug Stocks That Look to Beat the Market in 2016", "Novartis Gets FDA Nod for Label Expansion of Cosentyx", "Nivalis' N91115 Gets Orphan Drug Status for Cystic Fibrosis", "Flamel Technologies (FLML) in Focus: Stock Gains 5.8%", "Roche/AbbVie's Leukemia Drug Gets Breakthrough Status", "Weakness Seen in Radius Health (RDUS): Stock Tumbles 12%", "Juniper Pharmaceuticals (JNP) in Focus: Stock Jumps 7.8%", "Kite Pharma Signs Deal with Leiden University Medical Center", "Zoetis 2016 and 2017 View Impacted by Tax Woes in Belgium", "Celgene (CELG) Drops on Preliminary Results & 2016 Outlook", "Perrigo (PRGO) Raises 2016 Earnings Guidance, Shares Up", "Agios (AGIO) Provides Pipeline Updates and 2016 Strategy", "Intellipharmaceutics Up on Positive Rexista Oxycodone Data", "ARIAD's Iclusig Regulatory Application Filed in Japan", "HCA Holdings (HCA) Provides a Sneak Peek into Q4 Results", "New Strong Buy Stocks for January 8th", "New Strong Buy Stocks for January 6th", "New Strong Buy Stocks for January 4th", "Flamel Technologies (FLML) in Focus: Stock Tanks 15.7%", "NeuroDerm Begins Enrollment in Parkinson's Disease Study", "Ardelyx (ARDX) Rises: Stock Adds 6.2% in Session", "New Strong Buy Stocks for December 29th", "New Strong Buy Stocks for December 24th", "New Strong Buy Stocks for December 22nd", "New Strong Buy Stocks for December 7th", "Aerie Pharmaceuticals (AERI) Shares March Higher, Can It Continue?", "Aerie (AERI) Posts Narrower-than-Expected Loss in Q3", "Bristol-Myers to Acquire Cardioxyl, Focus on Heart Failure", "New Strong Buy Stocks for December 31st", "Will Aerie (AERI) Post a Wider-Than-Expected Loss in Q3?", "Thursday Sector Laggards: Drugs, Hospital & Medical Practitioners", "Why Aerie Pharmaceuticals Dropped 12% Today", "Monday Sector Laggards: Drugs, Biotechnology Stocks", "Pre-Market Most Active for Sep 17, 2015 : CVC, RAD, AERI, HSEB, TOT, FCAU, ABEV, XIV, AAPL, TVIX, ERIC, ITCI", "Aerie Reported Positive Phase III Data on Rhopressa", "Thursday Sector Leaders: Auto Dealerships, Drugs", "Zoetis Tops Q3 Earnings, Ups 2015 Bottom-Line Guidance", "After Hours Most Active for Sep 16, 2015 : OWW, NAVI, RAD, AERI, HBAN, XIV, EXEL, V, FIG, DCUA, GE, MSFT", "Can the Uptrend Continue for Aerie Pharmaceuticals (AERI)?", "Sucampo to Acquire R-Tech Ueno for About $278 Million", "Baron Funds Comments on Aerie Pharmaceuticals Inc.", "Health Care Sector Update for 06/19/2015: AERI,,HWAY", "Aerie Pharmaceuticals Up on Primary Endpoint Revision - Analyst Blog", "Aerie Pharmaceuticals (AERI) in Focus: Stock Soars 50% - Tale of the Tape", "Why Aerie Pharmaceuticals Is Rocketing Higher Today", "After Hours Most Active for Sep 16, 2015 : OWW, NAVI, RAD, AERI, HBAN, XIV, EXEL, V, FIG, DCUA, GE, MSFT", "Can the Uptrend Continue for Aerie Pharmaceuticals (AERI)?", "Sucampo to Acquire R-Tech Ueno for About $278 Million", "3 Types of Risks Facing Biotech Stocks", "Aerie (AERI) Plunges on Disappointing Rhopressa Data - Analyst Blog", "Aerie Pharmaceuticals (AERI) in Focus: Stock Tanks 64% - Tale of the Tape", "Pre-Market Most Active for Apr 24, 2015 : AERI, MSFT, ERIC, QQQ, AMZN, NLSN, INFY, AAPL, VALE, PBR, MT, DDD", "U.S. Stocks Set for Lower Open as Greece Woes Weigh, Housing Starts Fall Short", "Pre-Market Most Active for Jun 16, 2015 : FCAU, AAVL, AERI, GSK, BP, MT, NOK, TWTR, AAPL, QQQ, FTR, XIV", "U.S. Stock Futures Drop as Monetary-Policy Makers Meet Amid Escalation in Greece, Europe Tensions", "After-Hours Earnings Report for November 11, 2014 : FOSL, YY, TAHO, HMIN, LXFT, STKL, AERI, MGNX, SUPN, PFIE, FATE, CLSN", "A new eye-PO: Glaucoma biotech Inotek Pharmaceuticals files for an $86 million IPO", "Aerie Pharmaceuticals, Inc. (AERI) in Focus: Stock up 8.37% - Tale of the Tape", "Weakness Seen in TherapeuticsMD (TXMD): Stock Tumbles 8.4% - Tale of the Tape", "Health Care Sector Update for 04/24/2015: CELG, EHTH, AERI", "Tetraphase Pharmaceuticals (TTPH) Crumbles: Stock Tanks by 16.4% - Tale of the Tape", "Can the Rally in Aerie Pharmaceuticals (AERI) Shares Continue? - Tale of the Tape", "Alcobra (ADHD) Jumps: Stock Adds 5.9% in Session - Tale of the Tape", "Jazz Pharmaceuticals Public Limited Company (JAZZ) in Focus: Stock Moves 6.9% Higher - Tale of the Tape", "Zogenix, Inc. (ZGNX) Soars: Stock Adds 18.6% in Session - Tale of the Tape", "Tesaro (TSRO) in Focus: Stock Moves 8.9% Higher - Tale of the Tape", "Salix Pharmaceuticals (SLXP) Soars: Stock Adds 11.4% in Session - Tale of the Tape", "After Hours Most Active for Jul 9, 2014 : CSCO, QQQ, CMCSA, FOXA, CTXS, AERI", "Tetraphase Pharmaceuticals (TTPH) Crumbles: Stock Tanks by 16.4% - Tale of the Tape", "Heron Therapeutics (HRTX) in Focus: Stock Falls 8.9% in Session - Tale of the Tape", "Pre-Market Most Active for Jun 25, 2014 : STNG, HLT, FIO, RDS/A, MDCI, VOD, GLNG, MON, AERI, FB, TOT, QQQ", "Sector Update: Healthcare", "Sector Update: Healthcare Shares Mixed; Medical Action Industries Surges 95% Off Halt", "Sector Update: Health Stocks Ending Broadly Higher; Aerie Pharma Hits All-Time High After Testing New Glaucoma Drug", "IGI Laboratories (IG) Worth Watching: Stock Rises 6.2% - Tale of the Tape", "Ohr Pharmaceutical (OHRP) Soars: Stock Adds 16.9% in Session - Tale of the Tape", "Cardiome Pharma (CRME) Jumps: Stock Gains 7.3% - Tale of the Tape", "Genocea Biosciences (GNCA) Jumps: Stock Rises 8.7% - Tale of the Tape", "Heron Therapeutics (HRTX) in Focus: Stock Gains 7.5% - Tale of the Tape", "Weakness Seen in Cerulean Pharma (CERU): Stock Slumps 20.1% - Tale of the Tape", "Flamel Technologies (FLML) Jumps: Stock Adds 18.8% in Session - Tale of the Tape", "Aerie Pharmaceuticals (AERI) in Focus: Stock Moves 6.8% Higher - Tale of the Tape", "Sector Update: Healthcare", "Receptos (RCPT) in Focus: Stock Up 6.5% - Tale of the Tape", "WuXi PharmaTech (WX) in Focus: Stock Falls 6.4% - Tale of the Tape", "Karyopharm Therapeutics (KPTI) Jumps: Stock Up 93.5% - Tale of the Tape", "Can the Uptrend Continue for Aerie (AERI)? - Tale of the Tape", "Auxilium Pharmaceuticals (AUXL) in Focus: Stock Tumbles 7.8% - Tale of the Tape", "Hyperion (HPTX) in Focus: Stock Tumbles 9.5% - Tale of the Tape", "Aerie Pharmaceuticals, Inc. (AERI) in Focus: Stock Rises 5.71% - Tale of the Tape", "Endocyte (ECYT) in Focus: Stock Tanks 14% - Tale of the Tape", "Sector Update: Healthcare", "Healthcare Stocks Still Lagging Broader Market; Aerie Pharma Finds Higher Perch Ahead of Q3 Earnings", "Sector Update: Healthcare", "US IPO Recap: Twitter launches $1.3 billion IPO", "Aerie Pharmaceuticals prices IPO at $10, below the range", "5 US IPOs planned for the week of Oct 21", "Eye disease biotech Aerie Pharmaceuticals sets terms for $68 million IPO", "Healthcare Stocks Flat to Higher Pre-Market; Aerie Reports Positive Results from Phase 1 Pharmcokinetics Study of Eye Drops"], "Elapsed Time": ["MAY 7, 2020", "APR 1, 2020", "MAR 25, 2020", "FEB 21, 2020", "FEB 21, 2020", "FEB 21, 2020", "NOV 27, 2019", "NOV 26, 2019", "MAY 7, 2020", "NOV 7, 2019", "NOV 7, 2019", "OCT 21, 2019", "OCT 11, 2019", "OCT 9, 2019", "SEP 20, 2019", "SEP 10, 2019", "NOV 19, 2019", "JUN 26, 2019", "JUN 13, 2019", "MAR 28, 2019", "MAR 27, 2019", "MAR 22, 2019", "MAR 22, 2019", "MAR 19, 2019", "AUG 8, 2019", "JUN 26, 2019", "FEB 25, 2019", "FEB 5, 2019", "FEB 4, 2019", "JAN 18, 2019", "JAN 7, 2019", "DEC 6, 2018", "MAR 13, 2019", "FEB 26, 2019", "FEB 25, 2019", "FEB 5, 2019", "FEB 4, 2019", "JAN 18, 2019", "JAN 7, 2019", "AUG 28, 2018", "NOV 13, 2018", "AUG 9, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 3, 2018", "AUG 3, 2018", "AUG 2, 2018", "JUL 31, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 8, 2018", "JUN 5, 2018", "JUN 4, 2018", "MAY 10, 2018", "MAY 9, 2018", "MAY 2, 2018", "JUL 24, 2018", "APR 3, 2018", "APR 2, 2018", "MAR 7, 2018", "MAR 1, 2018", "FEB 27, 2018", "FEB 26, 2018", "FEB 26, 2018", "APR 9, 2018", "FEB 16, 2018", "FEB 7, 2018", "JAN 31, 2018", "JAN 24, 2018", "JAN 24, 2018", "JAN 24, 2018", "JAN 24, 2018", "FEB 23, 2018", "FEB 16, 2018", "FEB 7, 2018", "JAN 31, 2018", "JAN 24, 2018", "DEC 19, 2017", "DEC 11, 2017", "JAN 18, 2018", "DEC 7, 2017", "NOV 9, 2017", "NOV 7, 2017", "OCT 30, 2017", "OCT 23, 2017", "OCT 17, 2017", "OCT 13, 2017", "DEC 11, 2017", "OCT 12, 2017", "OCT 12, 2017", "OCT 11, 2017", "OCT 11, 2017", "OCT 11, 2017", "OCT 11, 2017", "OCT 13, 2017", "OCT 5, 2017", "OCT 5, 2017", "OCT 3, 2017", "OCT 3, 2017", "SEP 21, 2017", "SEP 20, 2017", "SEP 13, 2017", "OCT 11, 2017", "SEP 7, 2017", "AUG 25, 2017", "AUG 23, 2017", "AUG 17, 2017", "AUG 9, 2017", "AUG 7, 2017", "AUG 2, 2017", "SEP 11, 2017", "JUL 27, 2017", "JUL 24, 2017", "JUL 21, 2017", "JUN 29, 2017", "JUN 27, 2017", "JUN 7, 2017", "JUN 6, 2017", "AUG 2, 2017", "JUL 27, 2017", "MAY 25, 2017", "MAY 25, 2017", "MAY 25, 2017", "MAY 25, 2017", "MAY 19, 2017", "JUN 2, 2017", "MAY 30, 2017", "MAY 25, 2017", "MAY 25, 2017", "MAY 25, 2017", "MAY 3, 2017", "APR 26, 2017", "APR 21, 2017", "MAY 19, 2017", "MAY 18, 2017", "APR 7, 2017", "MAR 21, 2017", "MAR 13, 2017", "MAR 8, 2017", "MAR 7, 2017", "APR 19, 2017", "FEB 22, 2017", "JAN 5, 2017", "JAN 4, 2017", "DEC 27, 2016", "DEC 27, 2016", "NOV 3, 2016", "NOV 1, 2016", "MAR 1, 2017", "FEB 22, 2017", "JAN 5, 2017", "OCT 31, 2016", "OCT 31, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 27, 2016", "NOV 1, 2016", "OCT 27, 2016", "OCT 26, 2016", "OCT 3, 2016", "SEP 29, 2016", "SEP 21, 2016", "SEP 20, 2016", "SEP 16, 2016", "OCT 27, 2016", "OCT 27, 2016", "OCT 26, 2016", "SEP 15, 2016", "SEP 15, 2016", "SEP 15, 2016", "SEP 15, 2016", "SEP 15, 2016", "SEP 16, 2016", "SEP 15, 2016", "SEP 15, 2016", "SEP 15, 2016", "SEP 15, 2016", "AUG 24, 2016", "AUG 4, 2016", "AUG 2, 2016", "SEP 15, 2016", "AUG 1, 2016", "MAY 18, 2016", "MAY 3, 2016", "APR 29, 2016", "APR 27, 2016", "APR 13, 2016", "APR 7, 2016", "AUG 2, 2016", "MAR 28, 2016", "MAR 3, 2016", "MAR 2, 2016", "MAR 1, 2016", "FEB 18, 2016", "FEB 18, 2016", "FEB 18, 2016", "MAR 29, 2016", "JAN 20, 2016", "JAN 19, 2016", "JAN 18, 2016", "JAN 18, 2016", "JAN 18, 2016", "JAN 18, 2016", "JAN 15, 2016", "JAN 21, 2016", "JAN 14, 2016", "JAN 14, 2016", "JAN 14, 2016", "JAN 13, 2016", "JAN 12, 2016", "JAN 12, 2016", "JAN 12, 2016", "JAN 15, 2016", "JAN 11, 2016", "JAN 11, 2016", "JAN 8, 2016", "JAN 6, 2016", "JAN 4, 2016", "JAN 4, 2016", "DEC 31, 2015", "JAN 11, 2016", "DEC 29, 2015", "DEC 24, 2015", "DEC 22, 2015", "DEC 7, 2015", "NOV 27, 2015", "NOV 4, 2015", "NOV 3, 2015", "DEC 31, 2015", "NOV 2, 2015", "OCT 8, 2015", "SEP 21, 2015", "SEP 21, 2015", "SEP 17, 2015", "SEP 17, 2015", "SEP 17, 2015", "NOV 3, 2015", "SEP 16, 2015", "SEP 14, 2015", "AUG 27, 2015", "AUG 19, 2015", "JUN 19, 2015", "JUN 17, 2015", "JUN 17, 2015", "SEP 17, 2015", "SEP 16, 2015", "SEP 14, 2015", "JUN 16, 2015", "MAY 18, 2015", "APR 27, 2015", "APR 27, 2015", "APR 24, 2015", "JUN 16, 2015", "JUN 16, 2015", "JUN 16, 2015", "NOV 11, 2014", "NOV 5, 2014", "JUL 10, 2014", "JUL 10, 2014", "APR 24, 2015", "JUL 8, 2014", "JUL 7, 2014", "JUL 3, 2014", "JUL 3, 2014", "JUL 3, 2014", "JUL 2, 2014", "JUL 2, 2014", "JUL 9, 2014", "JUL 8, 2014", "JUN 26, 2014", "JUN 25, 2014", "JUN 25, 2014", "JUN 25, 2014", "JUN 25, 2014", "JUL 1, 2014", "JUN 24, 2014", "JUN 23, 2014", "JUN 23, 2014", "JUN 23, 2014", "JUN 23, 2014", "JUN 23, 2014", "JUN 20, 2014", "JUN 25, 2014", "JUN 19, 2014", "JUN 16, 2014", "JUN 16, 2014", "JUN 12, 2014", "JUN 12, 2014", "JUN 9, 2014", "JUN 9, 2014", "JUN 19, 2014", "JAN 9, 2014", "DEC 4, 2013", "DEC 4, 2013", "OCT 28, 2013", "OCT 25, 2013", "OCT 21, 2013", "OCT 15, 2013", "JAN 9, 2014"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/aerie-pharmaceuticals-inc-aeri-q1-2020-earnings-call-transcript-2020-05-07", "https://www.nasdaq.com/articles/so-your-biotech-announced-positive-phase-3-results-celebrating-could-be-premature-2020-04", "https://www.nasdaq.com/articles/healthcare-pro-james-flynn-picks-up-these-3-stocks-on-the-cheap-2020-03-25", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-inc-aeri-q4-2019-earnings-call-transcript-2020-02-21", "https://www.nasdaq.com/articles/heres-why-aerie-pharmaceuticals-jumped-as-much-as-14.4-today-2020-02-21", "https://www.nasdaq.com/articles/stock-alert%3A-aerie-pharma-aeri-catches-eye-2020-02-21", "https://www.nasdaq.com/articles/5-strong-buy-biotech-stocks-with-more-than-80-upside-2019-11-27", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity%3A-aeri-cvna-ntap-2019-11-26", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-inc-aeri-q1-2020-earnings-call-transcript-2020-05-07", "https://www.nasdaq.com/articles/why-aerie-pharmaceuticals-crashed-22.4-today-2019-11-07", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-inc-aeri-q3-2019-earnings-call-transcript-2019-11-07", "https://www.nasdaq.com/articles/is-aerie-pharmaceuticals-a-buy-2019-10-21", "https://www.nasdaq.com/articles/heres-why-aerie-pharmaceuticals-rose-as-much-as-21.8-today-2019-10-11", "https://www.nasdaq.com/articles/insiders-now-seeing-red-with-aeri-at-new-52-week-low-2019-10-09", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-20-2019%3A-nspr-htgm-aeri-jnj-pfe-abt-mrk-amgn-2019-09-20", "https://www.nasdaq.com/articles/tuesday-9-10-insider-buying-report%3A-aeri-nktr-2019-09-10", "https://www.nasdaq.com/articles/can-aerie-pharmaceuticals-go-from-1.5-of-the-glaucoma-market-to-40-2019-11-19", "https://www.nasdaq.com/articles/interesting-aeri-put-and-call-options-for-february-2020-2019-06-26", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-aeri-knx-tsn-2019-06-13", "https://www.nasdaq.com/articles/aerie-aeri-improves-22-ytd%3A-is-momentum-likely-to-sustain-2019-03-28-0", "https://www.nasdaq.com/articles/aerie-aeri-down-2.9-since-last-earnings-report%3A-can-it-rebound-2019-03-27", "https://www.nasdaq.com/articles/aerie-aeri-starts-phase-ii-study-on-eye-candidate-in-japan-2019-03-22", "https://www.nasdaq.com/articles/first-week-november-15th-options-trading-aerie-pharmaceuticals-2019-03-22", "https://www.nasdaq.com/articles/aerie-aeri-starts-phase-ii-study-on-eye-candidate-ar-1105-2019-03-19", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-inc.-aeri-q2-2019-earnings-call-transcript-2019-08-08", "https://www.nasdaq.com/articles/interesting-aeri-put-and-call-options-for-february-2020-2019-06-26", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-inc-aeri-q4-2018-earnings-conference-call-transcript-2019-02-25", "https://www.nasdaq.com/articles/9-best-biotech-stocks-buy-blowout-2019-2019-02-05", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-enters-overbought-territory%3A-is-a-drop-coming-2019-02-04", "https://www.nasdaq.com/articles/aeries-aeri-eye-care-candidate-to-enter-clinical-studies-2019-01-18", "https://www.nasdaq.com/articles/aeries-rhopressa-succeeds-in-study-on-japanese-patients-2019-01-07", "https://www.nasdaq.com/articles/aerie-aeri-down-19.9-since-last-earnings-report%3A-can-it-rebound-2018-12-06", "https://www.nasdaq.com/articles/aerie-aeri-receives-fda-nod-for-rocklatan-to-treat-glaucoma-2019-03-13", "https://www.nasdaq.com/articles/aerie-aeri-q4-earnings-miss-rhopressa-gains-traction-2019-02-26", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-inc-aeri-q4-2018-earnings-conference-call-transcript-2019-02-25", "https://www.nasdaq.com/articles/9-best-biotech-stocks-buy-blowout-2019-2019-02-05", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-enters-overbought-territory%3A-is-a-drop-coming-2019-02-04", "https://www.nasdaq.com/articles/aeries-aeri-eye-care-candidate-to-enter-clinical-studies-2019-01-18", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-breaks-below-200-day-moving-average-notable-aeri-2018-09-05", "https://www.nasdaq.com/articles/december-2019-options-now-available-aerie-pharmaceuticals-aeri-2018-08-28", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-aeri%3A-moving-average-crossover-alert-2018-11-13", "https://www.nasdaq.com/articles/has-aerie-pharmaceuticals-aeri-outpaced-other-medical-stocks-this-year-2018-08-09", "https://www.nasdaq.com/articles/jazz-pharmas-jazz-stock-down-despite-q2-earnings-beat-2018-08-08", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-aeri-reports-q2-loss-tops-revenue-estimates-2018-08-08", "https://www.nasdaq.com/articles/biomarin-bmrn-q2-earnings-miss-estimates-revenues-beat-2018-08-03", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-lng-aeri-epc-2018-08-03", "https://www.nasdaq.com/articles/medical-drugs-stock-outlook%3A-no-respite-from-near-term-pain-2018-08-02", "https://www.nasdaq.com/articles/aerie-aeri-to-report-q2-earnings%3A-whats-in-the-offing-2018-07-31", "https://www.nasdaq.com/articles/aerie-aeri-earnings-miss-in-q2-rhopressa-performs-well-2018-08-09", "https://www.nasdaq.com/articles/has-aerie-pharmaceuticals-aeri-outpaced-other-medical-stocks-this-year-2018-08-09", "https://www.nasdaq.com/articles/jazz-pharmas-jazz-stock-down-despite-q2-earnings-beat-2018-08-08", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-blk-aeri-zumz-2018-06-05", "https://www.nasdaq.com/articles/aeri-makes-bullish-cross-above-critical-moving-average-2018-06-04", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-now-oversold-aeri-2018-05-10", "https://www.nasdaq.com/articles/aerie-aeri-incurs-lower-loss-in-q1-launches-rhopressa-2018-05-09", "https://www.nasdaq.com/articles/whats-in-the-cards-for-aerie-aeri-this-earnings-season-2018-05-02", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-may-revolutionize-glaucoma-treatment-2018-07-24", "https://www.nasdaq.com/articles/analysts-expect-13-gains-ahead-vbr-2018-04-03", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-aeri-up-4.6-since-earnings-report%3A-can-it-continue-2018-04-02", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-breaks-above-200-day-moving-average-bullish-aeri-2018-03-07", "https://www.nasdaq.com/articles/aeries-aeri-q4-loss-wider-on-higher-operating-expenses-2018-03-01", "https://www.nasdaq.com/articles/why-earnings-season-could-be-great-for-aerie-pharmaceuticals-aeri-2018-02-27", "https://www.nasdaq.com/articles/will-admissions-drive-universal-healths-uhs-q4-earnings-2018-02-26", "https://www.nasdaq.com/articles/will-admissions-drive-universal-healths-uhs-q4-earnings-2018-02-26-0", "https://www.nasdaq.com/articles/commit-purchase-aerie-pharmaceuticals-40-earn-133-annualized-using-options-2018-04-09", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-evc-aeri-aa-2018-02-16", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-aeri-chrw-nxpi-2018-02-07", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-breaks-below-200-day-moving-average-notable-aeri-2018-01-31", "https://www.nasdaq.com/articles/health-care-sector-update-01242018-jnj-pfe-abt-mrk-amgn-stml-aeri-bsx-2018-01-24", "https://www.nasdaq.com/articles/why-valeants-162-climb-over-nine-months-makes-no-sense-2018-01-24", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-ter-aeri-mtor-2018-01-24", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-sees-ibd-rs-rating-improve-74-2018-01-24", "https://www.nasdaq.com/articles/can-rhopressas-approval-drive-aerie-aeri-in-q4-earnings-2018-02-23", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-evc-aeri-aa-2018-02-16", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-aeri-chrw-nxpi-2018-02-07", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-breaks-below-200-day-moving-average-notable-aeri-2018-01-31", "https://www.nasdaq.com/articles/health-care-sector-update-01242018-jnj-pfe-abt-mrk-amgn-stml-aeri-bsx-2018-01-24", "https://www.nasdaq.com/articles/aerie-aeri-gets-early-fda-approval-for-lead-drug-rhopressa-2017-12-19", "https://www.nasdaq.com/articles/why-is-aerie-aeri-down-5.9-since-the-last-earnings-report-2017-12-11", "https://www.nasdaq.com/articles/jacobs-jec-to-boost-organic-growth-on-energy-contract-2018-01-18", "https://www.nasdaq.com/articles/falling-earnings-estimates-signal-weakness-ahead-for-aerie-pharmaceuticals-aeri-2017-12-07", "https://www.nasdaq.com/articles/aerie-aeri-q3-loss-wider-than-expected-pipeline-in-focus-2017-11-09", "https://www.nasdaq.com/articles/is-a-surprise-coming-for-aerie-aeri-this-earnings-season-2017-11-07", "https://www.nasdaq.com/articles/is-aerie-aeri-poised-for-a-beat-this-earnings-season-2017-10-30", "https://www.nasdaq.com/articles/notable-monday-option-activity-aeri-cvlt-twtr-2017-10-23", "https://www.nasdaq.com/articles/aerie-aeri-up-on-fda-review-committee-result-for-rhopressa-2017-10-17", "https://www.nasdaq.com/articles/jacobs-south-african-jv-business-wins-new-deal-from-sasol-2017-10-13", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-clears-key-benchmark-hitting-80-plus-rs-rating-2017-12-11", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-aeri-surges%3A-stock-moves-16.2-higher-2017-10-12", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-scores-relative-strength-rating-upgrade-2017-10-12", "https://www.nasdaq.com/articles/wednesdays-etf-unusual-volume-iwv-2017-10-11", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-aeri-stz-dnkn-2017-10-11", "https://www.nasdaq.com/articles/drug-sent-biotech-fresh-high-theres-caveat-2017-10-11", "https://www.nasdaq.com/articles/health-care-sector-update-10112017-aeriaktxatec-2017-10-11", "https://www.nasdaq.com/articles/biotech-yo-yos-after-fda-panel-recommends-glaucoma-drug-2017-10-13", "https://www.nasdaq.com/articles/jacobs-jec-wins-new-transportation-contracts-from-nta-2017-10-05", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-earns-relative-strength-rating-upgrade-hits-key-threshold-2017-10-05", "https://www.nasdaq.com/articles/jacobs-jec-poised-to-grow-on-divestitures-contract-wins-2017-10-03", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-sees-ibd-rs-rating-climb-73-2017-10-03", "https://www.nasdaq.com/articles/first-week-aeri-may-2018-options-trading-2017-09-21", "https://www.nasdaq.com/articles/jacobs-jec-awarded-epcm-contract-by-aerie-pharmaceuticals-2017-09-20", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-aerie-aeri-stock-2017-09-13", "https://www.nasdaq.com/articles/stocks-showing-rising-market-leadership-aerie-pharmaceuticals-earns-82-rs-rating-2017-10", "https://www.nasdaq.com/articles/aerie-initiates-phase-iii-study-for-ophthalmic-drug-roclatan-2017-09-07", "https://www.nasdaq.com/articles/ultragenyx-files-bla-to-fda-for-hypophosphatemia-candidate-2017-08-25", "https://www.nasdaq.com/articles/ultragenyx-rare-posts-disappointing-phase-iii-ace-er-data-2017-08-23", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-lstr-cacc-aeri-2017-08-17", "https://www.nasdaq.com/articles/health-care-sector-update-08092017-aeri-2017-08-09", "https://www.nasdaq.com/articles/spectrum-pharmaceuticals-sppi-looks-good%3A-stock-jumps-22.2-2017-08-07", "https://www.nasdaq.com/articles/aerie-aeri-reports-narrower-than-expected-loss-in-q2-2017-08-02", "https://www.nasdaq.com/articles/why-is-aerie-aeri-up-10-since-the-last-earnings-report-2017-09-11", "https://www.nasdaq.com/articles/whats-in-the-cards-for-aerie-aeri-this-earnings-season-2017-07-27", "https://www.nasdaq.com/articles/new-strong-buy-stocks-july-24th-2017-07-24", "https://www.nasdaq.com/articles/commit-purchase-aerie-pharmaceuticals-40-earn-13-using-options-2017-07-21", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-looks-good%3A-stock-gains-10.4-2017-06-29", "https://www.nasdaq.com/articles/immune-design-imdz-shows-strength%3A-stock-moves-6.2-higher-2017-06-27", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-aerie-pharmaceuticals-aeri-2017-06-07", "https://www.nasdaq.com/articles/radius-health-rdus-looks-good%3A-stock-adds-10.5-in-session-2017-06-06", "https://www.nasdaq.com/articles/new-strong-buy-stocks-august-2nd-2017-08-02", "https://www.nasdaq.com/articles/whats-in-the-cards-for-aerie-aeri-this-earnings-season-2017-07-27", "https://www.nasdaq.com/articles/pre-market-most-active-may-25-2017-bby-qqq-cwh-anf-bp-aeri-sny-ntest-bcrx-xiv-sndx-nflx", "https://www.nasdaq.com/articles/why-sears-holdings-aerie-pharmaceuticals-and-guess-jumped-today-2017-05-25", "https://www.nasdaq.com/articles/aeries-ophthalmic-candidate-positive-in-registration-trial-2017-05-25", "https://www.nasdaq.com/articles/health-care-sector-update-05252017-aeribcrxcori-2017-05-25", "https://www.nasdaq.com/articles/glycomimetics-glyc-shows-strength%3A-stock-jumps-98.7-2017-05-19", "https://www.nasdaq.com/articles/why-is-aerie-aeri-up-40.4-since-the-last-earnings-report-2017-06-02", "https://www.nasdaq.com/articles/mei-pharma-meip-shows-strength%3A-stock-moves-7.6-higher-2017-05-30", "https://www.nasdaq.com/articles/why-aerie-pharmaceuticals-inc-skyrocketing-today-2017-05-25", "https://www.nasdaq.com/articles/pre-market-most-active-may-25-2017-bby-qqq-cwh-anf-bp-aeri-sny-ntest-bcrx-xiv-sndx-nflx", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-gra-aeri-gild-2017-05-03", "https://www.nasdaq.com/articles/aerie-aeri-posts-wider-than-expected-q1-loss-expenses-up-2017-05-03", "https://www.nasdaq.com/articles/what-awaits-aerie-pharmaceuticals-aeri-in-q1-earnings-2017-04-26", "https://www.nasdaq.com/articles/friday-421-insider-buying-report-jpm-aeri-2017-04-21", "https://www.nasdaq.com/articles/immunogen-imgn-shows-strength%3A-stock-up-14.2-higher-2017-05-19", "https://www.nasdaq.com/articles/cardiome-pharma-crme-looks-good%3A-stock-moves-6.1-higher-2017-05-18", "https://www.nasdaq.com/articles/aerie-aeri-down-12.9-since-earnings-report%3A-can-it-rebound-2017-04-07", "https://www.nasdaq.com/articles/valeants-vrx-glaucoma-candidate-gets-pdufa-date-from-fda-2017-03-21", "https://www.nasdaq.com/articles/aerie-resubmits-rhopressa-nda-roclatan-gains-traction-2017-03-13", "https://www.nasdaq.com/articles/aerie-aeri-q4-loss-widens-rhopressa-nda-resubmitted-2017-03-08", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-7-2017-hrb-urbn-abm-aeri-ncs-alg-edit-nmbl-boja-afam", "https://www.nasdaq.com/articles/implied-volatility-surging-for-aerie-pharmaceuticals-aeri-stock-options-2017-04-19", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-gbt-jack-aeri-2017-02-22", "https://www.nasdaq.com/articles/ocular-ocul-reports-positive-phase-iii-data-on-eye-drug-2017-01-05", "https://www.nasdaq.com/articles/inotek-itek-down-on-poor-phase-iii-glaucoma-drug-data-2017-01-04", "https://www.nasdaq.com/articles/commit-buy-aerie-pharmaceuticals-2250-earn-191-using-options-2016-12-27", "https://www.nasdaq.com/articles/aerie-aeri-rhopressa-regulatory-application-delayed-again-2016-12-27", "https://www.nasdaq.com/articles/aerie-aeri-q3-loss-wider-than-expected-pipeline-in-focus-2016-11-03", "https://www.nasdaq.com/articles/cigna-ci-poised-to-beat-on-earnings-in-q3%3A-heres-why-2016-11-01", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-aeri-q4-earnings%3A-what-to-expect-2017-03-01", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-gbt-jack-aeri-2017-02-22", "https://www.nasdaq.com/articles/exelixis-exel-q3-earnings%3A-whats-in-store-for-the-stock-2016-10-31", "https://www.nasdaq.com/articles/conatus-cnat-q3-earnings%3A-whats-in-store-for-the-stock-2016-10-31", "https://www.nasdaq.com/articles/celldex-cldx%3A-will-the-stock-surprise-in-q3-earnings-2016-10-31", "https://www.nasdaq.com/articles/endocyte-ecyt%3A-can-the-stock-surprise-in-q3-earnings-2016-10-28", "https://www.nasdaq.com/articles/ligand-lgnd-q3-earnings%3A-is-the-stock-likely-to-disappoint-2016-10-28", "https://www.nasdaq.com/articles/pfizer-pfe-to-post-q3-earnings%3A-how-will-the-stock-react-2016-10-27", "https://www.nasdaq.com/articles/horizon-hznp-q3-earnings-preview%3A-stock-to-disappoint-2016-11-01", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-aeri-q3-earnings%3A-will-it-beat-2016-10-27", "https://www.nasdaq.com/articles/can-prothena-prta-pull-a-surprise-this-earnings-season-2016-10-26", "https://www.nasdaq.com/articles/6-best-performing-drug-stocks-september-2016-10-03", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-could-still-be-bargain-after-its-run-2016-09-29", "https://www.nasdaq.com/articles/3-clinical-stage-biotechs-buy-ahead-fda-decisions-2016-09-21", "https://www.nasdaq.com/articles/whats-behind-aerie-pharmaceuticals-129-rally-today-2016-09-20", "https://www.nasdaq.com/articles/company-news-for-september-16-2016-2016-09-16", "https://www.nasdaq.com/articles/zoetis-zts-q3-earnings%3A-stock-likely-to-beat-estimates-2016-10-27", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-aeri-q3-earnings%3A-will-it-beat-2016-10-27", "https://www.nasdaq.com/articles/aerie-aeri-stock-up-on-positive-phase-iii-data-on-roclatan-2016-09-15", "https://www.nasdaq.com/articles/pre-market-most-active-sep-15-2016-aeg-aapl-azn-aeri-xiv-qqq-acrx-ttm-bac-tvix-nok-cs-2016", "https://www.nasdaq.com/articles/3-stocks-to-watch-thursday%3A-viacom-inc.-viab-aerie-pharmaceuticals-inc-aeri-and-bluebird", "https://www.nasdaq.com/articles/what-happened-stock-market-today-2016-09-15", "https://www.nasdaq.com/articles/close-update-stocks-rally-economic-data-cools-rate-hike-jitters-2016-09-15", "https://www.nasdaq.com/articles/health-care-sector-update-09152016-xncraerigbsn-2016-09-15", "https://www.nasdaq.com/articles/why-aerie-pharmaceuticals-shares-are-rallying-another-119-today-2016-09-16", "https://www.nasdaq.com/articles/stock-futures-trim-gains-econ-data-fails-extinguish-rate-hike-jitters-2016-09-15", "https://www.nasdaq.com/articles/aerie-aeri-stock-up-on-positive-phase-iii-data-on-roclatan-2016-09-15", "https://www.nasdaq.com/articles/pre-market-most-active-sep-15-2016-aeg-aapl-azn-aeri-xiv-qqq-acrx-ttm-bac-tvix-nok-cs-2016", "https://www.nasdaq.com/articles/3-stocks-to-watch-thursday%3A-viacom-inc.-viab-aerie-pharmaceuticals-inc-aeri-and-bluebird", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-wmt-aeri-opht-2016-08-24", "https://www.nasdaq.com/articles/aerie-aeri-q2-loss-wider-than-expected-pipeline-in-focus-2016-08-04", "https://www.nasdaq.com/articles/aerie-owner-buys-250000-shares-2016-08-02", "https://www.nasdaq.com/articles/midday-update-stocks-buoyed-anemic-retail-sales-support-sp-500-2120-2016-09-15", "https://www.nasdaq.com/articles/what-awaits-aerie-pharmaceuticals-aeri-in-q2-earnings-2016-08-01", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-box-aeri-aig-2016-05-18", "https://www.nasdaq.com/articles/aerie-aeri-q1-loss-wider-than-expected-pipeline-in-focus-2016-05-03", "https://www.nasdaq.com/articles/drug-stocks-q1-earnings-preview%3A-aegr-aeri-mack-prta-2016-04-29", "https://www.nasdaq.com/articles/aerie-aeri%3A-can-the-stock-pull-a-surprise-in-q1-earnings-2016-04-27", "https://www.nasdaq.com/articles/will-aerie-pharmaceuticals-aeri-continue-to-surge-higher-2016-04-13", "https://www.nasdaq.com/articles/thursdays-etf-movers-xph-xrt-2016-04-07", "https://www.nasdaq.com/articles/drug-stocks-to-watch-for-earnings-on-aug-3%3A-zts-exel-more-2016-08-02", "https://www.nasdaq.com/articles/health-care-sector-update-03282016-aerialdrapri-2016-03-28", "https://www.nasdaq.com/articles/health-care-sector-update-03032016-aericrmdssh-2016-03-03", "https://www.nasdaq.com/articles/aerie-aeri-q4-loss-wider-than-expected-pipeline-in-focus-2016-03-02", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-1-2016-rost-gwre-veev-asna-nktr-dar-sqm-bobe-tivo-chuy", "https://www.nasdaq.com/articles/health-care-sector-update-02182016-aeri-athx-cslt-2016-02-18", "https://www.nasdaq.com/articles/why-safety-data-sending-aerie-pharmaceuticals-soaring-today-2016-02-18", "https://www.nasdaq.com/articles/aerie-aeri-reports-positive-interim-results-on-rhopressa-2016-02-18", "https://www.nasdaq.com/articles/aerie-starts-dosing-in-registration-trial-mercury-2-on-roclatan-2016-03-29", "https://www.nasdaq.com/articles/synthetic-biologics-posts-encouraging-data-on-syn-010-2016-01-20", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-aerie-pharmaceuticals-united-therapeutics-pacira", "https://www.nasdaq.com/articles/nivalis-therapeutics-nvls-jumps%3A-stock-moves-up-15.5-2016-01-18", "https://www.nasdaq.com/articles/6-drug-stocks-that-look-to-beat-the-market-in-2016-2016-01-18", "https://www.nasdaq.com/articles/novartis-gets-fda-nod-for-label-expansion-of-cosentyx-2016-01-18", "https://www.nasdaq.com/articles/nivalis-n91115-gets-orphan-drug-status-for-cystic-fibrosis-2016-01-18", "https://www.nasdaq.com/articles/flamel-technologies-flml-in-focus%3A-stock-gains-5.8-2016-01-15", "https://www.nasdaq.com/articles/roche-abbvies-leukemia-drug-gets-breakthrough-status-2016-01-21", "https://www.nasdaq.com/articles/weakness-seen-in-radius-health-rdus%3A-stock-tumbles-12-2016-01-14", "https://www.nasdaq.com/articles/juniper-pharmaceuticals-jnp-in-focus%3A-stock-jumps-7.8-2016-01-14", "https://www.nasdaq.com/articles/kite-pharma-signs-deal-with-leiden-university-medical-center-2016-01-14", "https://www.nasdaq.com/articles/zoetis-2016-and-2017-view-impacted-by-tax-woes-in-belgium-2016-01-13", "https://www.nasdaq.com/articles/celgene-celg-drops-on-preliminary-results-2016-outlook-2016-01-12", "https://www.nasdaq.com/articles/perrigo-prgo-raises-2016-earnings-guidance-shares-up-2016-01-12", "https://www.nasdaq.com/articles/agios-agio-provides-pipeline-updates-and-2016-strategy-2016-01-12", "https://www.nasdaq.com/articles/intellipharmaceutics-up-on-positive-rexista-oxycodone-data-2016-01-15", "https://www.nasdaq.com/articles/ariads-iclusig-regulatory-application-filed-in-japan-2016-01-11", "https://www.nasdaq.com/articles/hca-holdings-hca-provides-a-sneak-peek-into-q4-results-2016-01-11", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-january-8th-2016-01-08", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-january-6th-2016-01-06", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-january-4th-2016-01-04", "https://www.nasdaq.com/articles/flamel-technologies-flml-in-focus%3A-stock-tanks-15.7-2016-01-04", "https://www.nasdaq.com/articles/neuroderm-begins-enrollment-in-parkinsons-disease-study-2015-12-31", "https://www.nasdaq.com/articles/ardelyx-ardx-rises%3A-stock-adds-6.2-in-session-2016-01-11", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-december-29th-2015-12-29", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-december-24th-2015-12-24", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-december-22nd-2015-12-22", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-december-7th-2015-12-07", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-aeri-shares-march-higher-can-it-continue-2015-11-27", "https://www.nasdaq.com/articles/aerie-aeri-posts-narrower-than-expected-loss-in-q3-2015-11-04", "https://www.nasdaq.com/articles/bristol-myers-to-acquire-cardioxyl-focus-on-heart-failure-2015-11-03", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-december-31st-2015-12-31", "https://www.nasdaq.com/articles/will-aerie-aeri-post-wider-expected-loss-q3-2015-11-02", "https://www.nasdaq.com/articles/thursday-sector-laggards-drugs-hospital-medical-practitioners-2015-10-08", "https://www.nasdaq.com/articles/why-aerie-pharmaceuticals-dropped-12-today-2015-09-21", "https://www.nasdaq.com/articles/monday-sector-laggards-drugs-biotechnology-stocks-2015-09-21", "https://www.nasdaq.com/articles/pre-market-most-active-sep-17-2015-cvc-rad-aeri-hseb-tot-fcau-abev-xiv-aapl-tvix-eric-itci", "https://www.nasdaq.com/articles/aerie-reported-positive-phase-iii-data-on-rhopressa-2015-09-17", "https://www.nasdaq.com/articles/thursday-sector-leaders-auto-dealerships-drugs-2015-09-17", "https://www.nasdaq.com/articles/zoetis-tops-q3-earnings-ups-2015-bottom-line-guidance-2015-11-03", "https://www.nasdaq.com/articles/after-hours-most-active-sep-16-2015-oww-navi-rad-aeri-hban-xiv-exel-v-fig-dcua-ge-msft", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-aerie-pharmaceuticals-aeri-2015-09-14", "https://www.nasdaq.com/articles/sucampo-to-acquire-r-tech-ueno-for-about-%24278-million-2015-08-27", "https://www.nasdaq.com/articles/baron-funds-comments-aerie-pharmaceuticals-inc-2015-08-19", "https://www.nasdaq.com/articles/health-care-sector-update-06192015-aerihway-2015-06-19", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-up-on-primary-endpoint-revision-analyst-blog-2015-06-17", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-aeri-in-focus%3A-stock-soars-50-tale-of-the-tape-2015-06-17", "https://www.nasdaq.com/articles/why-aerie-pharmaceuticals-rocketing-higher-today-2015-09-17", "https://www.nasdaq.com/articles/after-hours-most-active-sep-16-2015-oww-navi-rad-aeri-hban-xiv-exel-v-fig-dcua-ge-msft", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-aerie-pharmaceuticals-aeri-2015-09-14", "https://www.nasdaq.com/articles/why-aerie-pharmaceuticals-inc-shares-are-soaring-higher-2015-06-16", "https://www.nasdaq.com/articles/3-types-risks-facing-biotech-stocks-2015-05-18", "https://www.nasdaq.com/articles/aerie-aeri-plunges-on-disappointing-rhopressa-data-analyst-blog-2015-04-27", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-aeri-in-focus%3A-stock-tanks-64-tale-of-the-tape-2015-04-27", "https://www.nasdaq.com/articles/pre-market-most-active-apr-24-2015-aeri-msft-eric-qqq-amzn-nlsn-infy-aapl-vale-pbr-mt-ddd", "https://www.nasdaq.com/articles/us-stocks-set-lower-open-greece-woes-weigh-housing-starts-fall-short-2015-06-16", "https://www.nasdaq.com/articles/pre-market-most-active-jun-16-2015-fcau-aavl-aeri-gsk-bp-mt-nok-twtr-aapl-qqq-ftr-xiv-2015", "https://www.nasdaq.com/articles/us-stock-futures-drop-monetary-policy-makers-meet-amid-escalation-greece-europe-tensions", "https://www.nasdaq.com/articles/after-hours-earnings-report-november-11-2014-fosl-yy-taho-hmin-lxft-stkl-aeri-mgnx-supn", "https://www.nasdaq.com/articles/new-eye-po-glaucoma-biotech-inotek-pharmaceuticals-files-86-million-ipo-2014-11-05", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-inc.-aeri-in-focus%3A-stock-up-8.37-tale-of-the-tape-2014-07-10", "https://www.nasdaq.com/articles/weakness-seen-in-therapeuticsmd-txmd%3A-stock-tumbles-8.4-tale-of-the-tape-2014-07-10", "https://www.nasdaq.com/articles/health-care-sector-update-04242015-celg-ehth-aeri-2015-04-24", "https://www.nasdaq.com/articles/tetraphase-pharmaceuticals-ttph-crumbles%3A-stock-tanks-by-16.4-tale-of-the-tape-2014-07-08", "https://www.nasdaq.com/articles/can-the-rally-in-aerie-pharmaceuticals-aeri-shares-continue-tale-of-the-tape-2014-07-07", "https://www.nasdaq.com/articles/alcobra-adhd-jumps%3A-stock-adds-5.9-in-session-tale-of-the-tape-2014-07-03", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-public-limited-company-jazz-in-focus%3A-stock-moves-6.9-higher-tale-of", "https://www.nasdaq.com/articles/zogenix-inc.-zgnx-soars%3A-stock-adds-18.6-in-session-tale-of-the-tape-2014-07-03", "https://www.nasdaq.com/articles/tesaro-tsro-in-focus%3A-stock-moves-8.9-higher-tale-of-the-tape-2014-07-02", "https://www.nasdaq.com/articles/salix-pharmaceuticals-slxp-soars%3A-stock-adds-11.4-in-session-tale-of-the-tape-2014-07-02", "https://www.nasdaq.com/articles/after-hours-most-active-jul-9-2014-csco-qqq-cmcsa-foxa-ctxs-aeri-2014-07-09", "https://www.nasdaq.com/articles/tetraphase-pharmaceuticals-ttph-crumbles%3A-stock-tanks-by-16.4-tale-of-the-tape-2014-07-08", "https://www.nasdaq.com/articles/heron-therapeutics-hrtx-in-focus%3A-stock-falls-8.9-in-session-tale-of-the-tape-2014-06-26", "https://www.nasdaq.com/articles/pre-market-most-active-jun-25-2014-stng-hlt-fio-rdsa-mdci-vod-glng-mon-aeri-fb-tot-qqq", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-06-25-1", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-mixed-medical-action-industries-surges-95-halt-2014-06-25", "https://www.nasdaq.com/articles/sector-update-health-stocks-ending-broadly-higher-aerie-pharma-hits-all-time-high-after", "https://www.nasdaq.com/articles/igi-laboratories-ig-worth-watching%3A-stock-rises-6.2-tale-of-the-tape-2014-07-01", "https://www.nasdaq.com/articles/ohr-pharmaceutical-ohrp-soars%3A-stock-adds-16.9-in-session-tale-of-the-tape-2014-06-24", "https://www.nasdaq.com/articles/cardiome-pharma-crme-jumps%3A-stock-gains-7.3-tale-of-the-tape-2014-06-23", "https://www.nasdaq.com/articles/genocea-biosciences-gnca-jumps%3A-stock-rises-8.7-tale-of-the-tape-2014-06-23", "https://www.nasdaq.com/articles/heron-therapeutics-hrtx-in-focus%3A-stock-gains-7.5-tale-of-the-tape-2014-06-23", "https://www.nasdaq.com/articles/weakness-seen-in-cerulean-pharma-ceru%3A-stock-slumps-20.1-tale-of-the-tape-2014-06-23", "https://www.nasdaq.com/articles/flamel-technologies-flml-jumps%3A-stock-adds-18.8-in-session-tale-of-the-tape-2014-06-23", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-aeri-in-focus%3A-stock-moves-6.8-higher-tale-of-the-tape-2014-06-20", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-06-25", "https://www.nasdaq.com/articles/receptos-rcpt-in-focus%3A-stock-up-6.5-tale-of-the-tape-2014-06-19", "https://www.nasdaq.com/articles/wuxi-pharmatech-wx-in-focus%3A-stock-falls-6.4-tale-of-the-tape-2014-06-16", "https://www.nasdaq.com/articles/karyopharm-therapeutics-kpti-jumps%3A-stock-up-93.5-tale-of-the-tape-2014-06-16", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-aerie-aeri-tale-of-the-tape-2014-06-12", "https://www.nasdaq.com/articles/auxilium-pharmaceuticals-auxl-in-focus%3A-stock-tumbles-7.8-tale-of-the-tape-2014-06-12", "https://www.nasdaq.com/articles/hyperion-hptx-in-focus%3A-stock-tumbles-9.5-tale-of-the-tape-2014-06-09", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-inc.-aeri-in-focus%3A-stock-rises-5.71-tale-of-the-tape-2014-06-09", "https://www.nasdaq.com/articles/endocyte-ecyt-in-focus%3A-stock-tanks-14-tale-of-the-tape-2014-06-19", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-01-09-1", "https://www.nasdaq.com/articles/healthcare-stocks-still-lagging-broader-market-aerie-pharma-finds-higher-perch-ahead-q3", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-12-04", "https://www.nasdaq.com/articles/us-ipo-recap-twitter-launches-13-billion-ipo-2013-10-28", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-prices-ipo-10-below-range-2013-10-25", "https://www.nasdaq.com/articles/5-us-ipos-planned-week-oct-21-2013-10-21", "https://www.nasdaq.com/articles/eye-disease-biotech-aerie-pharmaceuticals-sets-terms-68-million-ipo-2013-10-15", "https://www.nasdaq.com/articles/healthcare-stocks-flat-higher-pre-market-aerie-reports-positive-results-phase-1"], "Content": []}